Ruizhi He

1.3k total citations
28 papers, 684 citations indexed

About

Ruizhi He is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ruizhi He has authored 28 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Ruizhi He's work include Pancreatic and Hepatic Oncology Research (7 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (7 papers). Ruizhi He is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (7 papers). Ruizhi He collaborates with scholars based in China, United States and Sweden. Ruizhi He's co-authors include Xingjun Guo, Xiuhui Shi, Shutao Pan, Chunle Zhao, Min Wang, Ming Shen, Yan Zhao, Renyi Qin, Min Zhou and Renyi Qin and has published in prestigious journals such as PLoS ONE, Scientific Reports and Advanced Science.

In The Last Decade

Ruizhi He

25 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruizhi He China 16 412 287 163 118 91 28 684
Xiaobing Chen China 15 546 1.3× 344 1.2× 114 0.7× 81 0.7× 78 0.9× 43 817
Jiankang Zhu China 12 404 1.0× 248 0.9× 173 1.1× 70 0.6× 87 1.0× 38 714
Xiuhui Shi China 17 548 1.3× 374 1.3× 256 1.6× 90 0.8× 133 1.5× 21 862
Siyuan Yan China 15 366 0.9× 184 0.6× 99 0.6× 135 1.1× 68 0.7× 33 606
Shuang Lin China 15 442 1.1× 255 0.9× 163 1.0× 69 0.6× 48 0.5× 34 778
Ze Yu China 16 381 0.9× 265 0.9× 160 1.0× 55 0.5× 103 1.1× 52 764
Qiong Xu China 13 550 1.3× 288 1.0× 96 0.6× 76 0.6× 90 1.0× 29 724
Fuchen Liu China 15 373 0.9× 235 0.8× 108 0.7× 127 1.1× 44 0.5× 51 727
Naoshad Mohammad India 10 412 1.0× 305 1.1× 137 0.8× 82 0.7× 56 0.6× 11 668

Countries citing papers authored by Ruizhi He

Since Specialization
Citations

This map shows the geographic impact of Ruizhi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruizhi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruizhi He more than expected).

Fields of papers citing papers by Ruizhi He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruizhi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruizhi He. The network helps show where Ruizhi He may publish in the future.

Co-authorship network of co-authors of Ruizhi He

This figure shows the co-authorship network connecting the top 25 collaborators of Ruizhi He. A scholar is included among the top collaborators of Ruizhi He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruizhi He. Ruizhi He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yu-Hui, Ruizhi He, Wenjia Wang, et al.. (2025). Dysregulated RNA m6A Methylation Contributes to the Metastasis of Gallbladder Cancer Through miR‐146a‐5p. Journal of Cellular and Molecular Medicine. 29(15). e70764–e70764. 1 indexed citations
2.
Lu, Jianchen, Ruizhi He, Yong Zhang, et al.. (2024). From 2D AgTe Monolayer to 1D AgTe Nanowires: Tellurium Concentration Modulated Structural and Electronic Properties Transformation. Small Methods. 9(10). e2402025–e2402025.
3.
Peng, Feng, Yechen Feng, Shuo Yu, et al.. (2024). Pan-cancer analysis of B3GNT5 with potential implications for cancer immunotherapy and cancer stem cell stemness. PLoS ONE. 19(12). e0314609–e0314609. 1 indexed citations
4.
Peng, Feng, Ruizhi He, Yuhui Liu, et al.. (2024). MiR-200b-3p elevates 5-FU sensitivity in cholangiocarcinoma cells via autophagy inhibition by targeting KLF4. Non-coding RNA Research. 9(4). 1098–1110. 1 indexed citations
5.
Peng, Feng, et al.. (2023). Development of a difficulty scoring system for laparoscopic pancreatoduodenectomy in the initial stage of the learning curve: a retrospective cohort study. International Journal of Surgery. 109(4). 660–669. 3 indexed citations
6.
Gong, Jun, Yuhui Liu, Wenjia Wang, et al.. (2023). TRIM21‐Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers. Advanced Science. 10(29). e2302318–e2302318. 31 indexed citations
7.
8.
Shi, Xiuhui, Min Wang, Yuqing Zhang, et al.. (2022). Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inhibition. EBioMedicine. 86. 104352–104352. 24 indexed citations
9.
He, Ruizhi, Taoyuan Yin, Shutao Pan, et al.. (2022). One hundred most cited article related to pancreaticoduodenectomy surgery: A bibliometric analysis. International Journal of Surgery. 104. 106775–106775. 7 indexed citations
10.
Liu, Yuhui, Chengjian Shi, Zheng He, et al.. (2021). Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplatin sensitivity in pancreatic cancer cells. International Journal of Biological Sciences. 17(2). 589–602. 62 indexed citations
11.
He, Ruizhi, Min Wang, Chunle Zhao, et al.. (2019). TFEB-driven autophagy potentiates TGF-β induced migration in pancreatic cancer cells. Journal of Experimental & Clinical Cancer Research. 38(1). 340–340. 62 indexed citations
12.
Zhao, Chunle, Ruizhi He, Ming Shen, et al.. (2019). PINK1/Parkin-Mediated Mitophagy Regulation by Reactive Oxygen Species Alleviates Rocaglamide A-Induced Apoptosis in Pancreatic Cancer Cells. Frontiers in Pharmacology. 10. 968–968. 42 indexed citations
13.
He, Ruizhi, Xiuhui Shi, Min Zhou, et al.. (2018). Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB. Toxicology and Applied Pharmacology. 356. 159–171. 48 indexed citations
14.
Xie, Yu, Hang Zhang, Xingjun Guo, et al.. (2018). Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites. Cell Death and Disease. 9(2). 249–249. 24 indexed citations
15.
Shi, Xiuhui, Yan Zhao, Ruizhi He, et al.. (2018). Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma. Oncotarget. 9(36). 24248–24259. 26 indexed citations
16.
Shi, Xiuhui, Xu Li, Hang Zhang, et al.. (2018). A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data. Scientific Reports. 8(1). 7638–7638. 41 indexed citations
17.
Chen, Hua, Ruizhi He, Xiuhui Shi, et al.. (2018). Meta-analysis on resected pancreatic cancer: a comparison between adjuvant treatments and gemcitabine alone. BMC Cancer. 18(1). 1034–1034. 6 indexed citations
18.
Chen, Hua, Chunle Zhao, Ruizhi He, et al.. (2018). Danthron suppresses autophagy and sensitizes pancreatic cancer cells to doxorubicin. Toxicology in Vitro. 54. 345–353. 37 indexed citations
19.
Shi, Xiuhui, Min Wang, Xiaodong Xu, et al.. (2017). LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells. Oncotarget. 8(35). 58394–58404. 55 indexed citations
20.
Guo, Xingjun, Min Wang, Yan Zhao, et al.. (2015). Par3 regulates invasion of pancreatic cancer cells via interaction with Tiam1. Clinical and Experimental Medicine. 16(3). 357–365. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaobing Chen Breakdown of academic impact, for papers by Jiankang Zhu Breakdown of academic impact, for papers by Xiuhui Shi Breakdown of academic impact, for papers by Siyuan Yan Breakdown of academic impact, for papers by Shuang Lin Breakdown of academic impact, for papers by Ze Yu Breakdown of academic impact, for papers by Qiong Xu Breakdown of academic impact, for papers by Fuchen Liu Breakdown of academic impact, for papers by Naoshad Mohammad
Rankless by CCL
2026